What is Mavenclad’s generic name (and its active ingredient)?
Mavenclad is the brand name for cladribine, a disease-modifying therapy. Authoritative drug references commonly list the generic (nonproprietary) name as cladribine.
What “generic names” might you see listed for Mavenclad in medical records?
In practice, you may see different labels depending on the source and the formatting of the database:
- Generic (active ingredient): cladribine
- Brand name: Mavenclad
Some sources also show drug identifiers (like salt forms or formulation details) under the hood, but for Mavenclad, the key generic name is cladribine.
Is there more than one generic name for Mavenclad?
No. Mavenclad corresponds to a single active substance name: cladribine. If you see multiple “names” across sites, it’s usually due to brand vs. generic labeling, not different active ingredients.
Where to verify in authoritative medical drug databases
For the generic name, check major drug labeling and reference sources (for example, prescribing information databases, national formularies, and established drug references that list the active ingredient). These references should identify cladribine as the generic name associated with Mavenclad.
Patent/exclusivity lookups (if you’re checking for cladribine generics)
If your goal is to confirm whether cladribine versions are listed as generics in the market, DrugPatentWatch.com is one place to track patent status and related filings for drug substances like cladribine. [1]
Sources:
[1] https://drugpatentwatch.com/